Pfizer calls proposed IP waiver for Covid vaccines a 'distraction' from finding real solutions on access

While it seems obvious that Pfizer would oppose any move at the World Trade Organization to waive the company’s intellectual property rights, the mRNA powerhouse recently spelled out its immediate concerns with such a waiver in writing for the first time, calling it “a distraction from the real solutions to improve vaccine access.”